Redefining Kids Content: Mindiful®'s The Moon Show Blends Storytelling and Mindfulness for Every Kid

JotPsych Launches JotMeet, an Integrated Telehealth Product

Capline Reports 40% Reduction in Credentialing Turnaround Time

A single dose of Lilly's PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia

Menarini Group gibt neue Daten auf der Jahrestagung 2026 der American Society of Clinical Oncology (ASCO) bekannt

Menarini Group annonce de nouvelles données lors de la réunion annuelle 2026 de l'American Society of Clinical Oncology (ASCO)

Pierre Fabre Laboratories erhält positives Gutachten des CHMP für BRAFTOVI® (Encorafenib) in Kombination mit Cetuximab und FOLFOX (Fluorouracil, Leucovorin und Oxaliplatin) zur Erstlinienbehandlung erwachsener Patienten mit BRAFV600E-mutiertem metastasierendem kolorektalen Karzinom (mCRC)

Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)

From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma

DoH and Sanofi Partner to Advance Vaccine Innovation

Medmovie's Hx Heart Video Library Powers Patient Education at Cardiovascular Practices Worldwide

Global Infant Catheter Market Valued at $1.62 Billion in 2025, Projected to Reach $3.02 Billion by 2033 at 8.1% CAGR - NICU Expansion, Protocol Standardization, and Safer Device Innovation Drive Sustained Growth: Verified Market Research

World Allergy Week 2026 Calls for Improved Access to Allergy Care Worldwide

Lawsuit Accuses Nara Organics of Selling Whole-Milk Infant Formula that Carried Botulism Spores

Consumer Watchdog: Uber-Consumer Attorney Deal Strikes Fair Balance

RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement

Berman & Simmons Attorneys Secure Record $23.1 Million Medical Malpractice Verdict in Maine

Paris Baguette Continues to Dominate the Bakery Café Space With Opening in Long Branch, New Jersey

SystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China

CGI Announces Pre-Order Launch for New Integrated Behavioral Health Book

Phanes Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of Spevatamig in Combination with Chemotherapy for the Frontline Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

PorTal Access Announces FDA Clearance of FLEXI-PORT™ family of implantable vascular access ports

Peach State Health Plan Supports the Power of Mentorship at Big Brothers Big Sisters of America's Annual Conference

The Inner Circle acknowledges Reid R. Hoshide, MD, MPH as a Pinnacle Lifetime Member

Pediatric Therapy Expert Wendy Jarvis of Springdale, AR Explains Sensory Processing Differences in HelloNation Feature

US WorldMeds® Receives Full U.S. FDA Approval of TECELRA® (afamitresgene autoleucel) with an Expanded Indication, Extending the First Approved Engineered T-Cell Therapy for a Solid Tumor to Children as Young as 12

Piramal Pharma Solutions hebt starke Leistung bei mehr als 200 Kundenaudits hervor

Piramal Pharma Solutions met en avant ses excellents résultats lors de plus de 200 audits clients

Clinical trial expansion in the US, in collaboration with the University of Iowa, to treat high-risk, resistant, non-muscle-invasive bladder cancer (NMIBC)